Bullish Signal: Motilal Oswal Recommends SUNPHARMA, FORTIS, GRASIM

Chandan Taparia from Motilal Oswal has issued 'buy' recommendations for Sun Pharmaceutical Industries, Fortis Healthcare, and Grasim Industries for May 12, 2026. This provides specific actionable advice to traders looking for entry points in the current market.

Such recommendations from a reputable analyst like Chandan Taparia often lead to increased trading activity and potential price appreciation in the short term for the mentioned stocks. It offers a directional cue for investors, especially after a day of significant market correction.

SUNPHARMA, FORTIS, and GRASIM are likely to see positive sentiment and increased buying interest at market open. This could lead to an upward price movement, potentially outperforming the broader market, especially if the overall market sentiment improves after yesterday's crash.

Traders should monitor the opening prices and volumes of these three stocks. Look for confirmation of buying interest and consider the broader market's reaction to yesterday's fall. Setting appropriate stop-losses is crucial given the recent volatility.

• •Chandan Taparia of Motilal Oswal recommended three stocks to buy today, May 12, 2026.
• •The recommended stocks are Sun Pharmaceutical Industries, Fortis Healthcare, and Grasim Industries.
• •The Nifty50 recently closed above 24,350, while the Sensex experienced a significant crash yesterday (May 11, 2026), falling over 1,312 points.
• •Risk flag: Potential for broader market weakness to override stock-specific recommendations.
• •Risk flag: Regulatory changes or USFDA actions could impact pharma stocks.